Development and Validation of Risk Prediction Model for In-hospital Mortality Among Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease Between 2015 and 2019
单位:[1]Institute of Clinical Medical Sciences, China–Japan Friendship Hospital, Beijing, China[2]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[3]National Clinical Research Center for Respiratory Diseases, Beijing, China[4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China,[5]Department of Medical Records, China–Japan Friendship Hospital, Beijing, China[6]Department of Medical Administration, China–Japan Friendship Hospital, Beijing, China
Background: In patients with chronic obstructive pulmonary disease (COPD), acute exacerbations affect patients' health and can lead to death. This study was aimed to develop a prediction model for in-hospital mortality in patients with acute exacerbations of COPD (AECOPD). Method: A retrospective study was performed in patients hospitalized for AECOPD between 2015 and 2019. Patients admitted between 2015 and 2017 were included to develop model and individuals admitted in the following 2 years were included for external validation. We analyzed variables that were readily available in clinical practice. Given that death was a rare outcome in this study, we fitted Firth penalized logistic regression. C statistic and calibration plot quantified the model performance. Optimism-corrected C statistic and slope were estimated by bootstrapping. Accordingly, the prediction model was adjusted and then transformed into risk score. Result: Between 2015 and 2017, 1,096 eligible patients were analyzed, with a mean age of 73 years and 67.8% male. The in-hospital mortality was 2.6%. Compared to survivors, non-survivors were older, more admitted from emergency, more frequently concomitant with respiratory failure, pneumothorax, hypoxic-hypercarbic encephalopathy, and had longer length of stay (LOS). Four variables were included into the final model: age, respiratory failure, pneumothorax, and LOS. In internal validation, C statistic was 0.9147, and the calibration slope was 1.0254. Their optimism-corrected values were 0.90887 and 0.9282, respectively, indicating satisfactory discrimination and calibration. When externally validated in 700 AECOPD patients during 2018 and 2019, the model demonstrated good discrimination with a C statistic of 0.8176. Calibration plot illustrated a varying discordance between predicted and observed mortality. It demonstrated good calibration in low-risk patients with predicted mortality rate <= 10% (P = 0.3253) but overestimated mortality in patients with predicted rate >10% (P < 0.0001). The risk score of 20 was regarded as a threshold with an optimal Youden index of 0.7154. Conclusion: A simple prediction model for AECOPD in-hospital mortality has been developed and externally validated. Based on available data in clinical setting, the model could serve as an easily used instrument for clinical decision-making. Complications emerged as strong predictors, underscoring an important role of disease management in improving patients' prognoses during exacerbation episodes.
基金:
National Key R&D Program of China [2016YFC1304301, 2016YFC0206502, 2016YFC1303900, 2018YFC1315100]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2018-I2M-1-001]; Medical record-based study for respiratory diseases in hospitalized patients [Q[2017]001]; Science Foundation of China-Japan Friendship Hospital for junior researchers [2017-1-QN-3]
第一作者单位:[1]Institute of Clinical Medical Sciences, China–Japan Friendship Hospital, Beijing, China[2]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[3]National Clinical Research Center for Respiratory Diseases, Beijing, China[4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China,
通讯作者:
通讯机构:[2]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[3]National Clinical Research Center for Respiratory Diseases, Beijing, China[4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China,
推荐引用方式(GB/T 7714):
Dong Fen,Ren Xiaoxia,Huang Ke,et al.Development and Validation of Risk Prediction Model for In-hospital Mortality Among Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease Between 2015 and 2019[J].FRONTIERS in MEDICINE.2021,8:doi:10.3389/fmed.2021.630870.
APA:
Dong, Fen,Ren, Xiaoxia,Huang, Ke,Wang, Yanyan,Jiao, Jianjun&Yang, Ting.(2021).Development and Validation of Risk Prediction Model for In-hospital Mortality Among Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease Between 2015 and 2019.FRONTIERS in MEDICINE,8,
MLA:
Dong, Fen,et al."Development and Validation of Risk Prediction Model for In-hospital Mortality Among Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease Between 2015 and 2019".FRONTIERS in MEDICINE 8.(2021)